HALOZYME THERAPEUTICS, INC. (HALO) Net margin 2016–2025
HALOZYME THERAPEUTICS, INC. (HALO) net profit margin by fiscal year — reported net income divided by reported revenue.
22.7%FY2025 · since FY2016: -70.2% → 22.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 22.7% | -21.0 pp |
| FY2024 | 43.7% | +9.8 pp |
| FY2023 | 34.0% | +3.3 pp |
| FY2022 | 30.6% | -60.2 pp |
| FY2021 | 90.8% | +42.6 pp |
| FY2020 | 48.2% | +85.1 pp |
| FY2019 | -36.9% | +16.0 pp |
| FY2018 | -52.9% | -72.8 pp |
| FY2017 | 19.9% | +90.1 pp |
| FY2016 | -70.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice